Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation

Dariusz A Kosior1, Beata Wozakowska-Kapłon, Mariusz Jasik

  • 1I Katedra i Klinika Kardiologii, Akademia Medyczna, ul. Banacha 1 a, 02-097 Warszawa. dkosior@amwaw.edu.pl

Kardiologia Polska
|December 29, 2005
PubMed

Insights

Amiodarone pretreatment followed by repeat direct current cardioversion safely restores sinus rhythm in about 80.6% of persistent atrial fibrillation patients. Over 72.2% maintained sinus rhythm at 12 months on low-dose amiodarone.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Persistent atrial fibrillation (AF) poses a significant challenge for rhythm control.
  • Direct current cardioversion (DCC) is a common treatment for AF, but success rates can be limited after initial attempts.
  • Amiodarone is an antiarrhythmic drug with a role in managing AF.

Purpose of the Study:

  • To evaluate the safety and effectiveness of amiodarone pretreatment before repeat direct current cardioversion (DCC) for persistent atrial fibrillation (AF).
  • To assess the long-term maintenance of sinus rhythm (SR) after successful DCC with amiodarone therapy.

Main Methods:

  • A study involving 67 patients with persistent AF after an unsuccessful DCC.
  • Patients received oral amiodarone loading (cumulative dose up to 12.0-16.0 g) as an outpatient procedure before repeat DCC.
  • Follow-up was conducted for 12 months, monitoring SR maintenance and adverse events.

Main Results:

  • Spontaneous conversion to sinus rhythm (SR) occurred in 19.2% of patients during amiodarone pretreatment.
  • Repeat DCC successfully restored SR in 76% of patients, leading to an overall restoration rate of approximately 80.6%.
  • At 12 months, 72.2% of patients maintained SR on a low daily maintenance dose of amiodarone (100-200 mg).

Conclusions:

  • Amiodarone pretreatment combined with repeat DCC is an effective strategy for restoring and maintaining sinus rhythm in persistent AF.
  • The procedure was found to be safe, with only minor complications reported.
  • Long-term maintenance of SR is achievable with low-dose amiodarone therapy post-cardioversion.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...